Douglas J. Williamson's most recent trade in Acadia Pharmaceuticals Inc was a trade of 237,296 Non-Qualified Stock Option (Right to Buy) done . Disclosure was reported to the exchange on Feb. 10, 2023.
Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
---|---|---|---|---|---|---|---|---|---|---|
Acadia Pharmaceuticals Inc | Douglas J. Williamson | Executive VP, Research & Dev | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Feb 2023 | 237,296 | 237,296 | - | - | Non-Qualified Stock Option (Right to Buy) | |
Acadia Pharmaceuticals Inc | Douglas J. Williamson | Executive VP, Research & Dev | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Feb 2023 | 50,655 | 50,655 | - | - | Restricted Stock Units |